Journal ArticleDOI
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Chloe L. Thio,Eric C. Seaberg,Richard L. Skolasky,John P. Phair,Barbara R. Visscher,Alvaro Muñoz,David L. Thomas +6 more
TLDR
Individuals coinfected with HIV-1 and HBV, especially those with low CD4+ nadir counts, are at increased risk for liver-related mortality, underscoring the importance of prevention, identification, and comprehensive management of hepatitis B in people infected withAIDS.Citations
More filters
Journal ArticleDOI
Epidemiology and natural history of hepatocellular carcinoma.
TL;DR: In recent years, the incidence of HCC has decreased in some high-risk countries and increased in some low- Risk countries, likely related to public health efforts in Asia and the increase in hepatitis C virus infection in low- risk countries.
Journal ArticleDOI
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol
Dominique Salmon-Ceron,Charlotte Lewden,Philippe Morlat,Sibylle Bevilacqua,Eric Jougla,Fabrice Bonnet,Laurence Heripret,Dominique Costagliola,Thierry May,Geneviève Chêne +9 more
TL;DR: It is shown that liver disease is now a leading cause of death among HIV-HCV co-infected patients and is becoming an important cause ofdeath among HIV/AIDS co- Infected patients, with the risk of death from liver disease highest in patients co- infected by both HCV and HBV.
Journal Article
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents
Jonathan E. Kaplan,Constance A. Benson,King K. Holmes,John T. Brooks,Alice Pau PharmD,Henry Masur +5 more
TL;DR: This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents and adds malaria to the list of OIs that might be acquired during international travel.
Journal ArticleDOI
Clinical implications of HIV and hepatitis B co-infection in Asia and Africa.
TL;DR: In this paper, the authors discuss the epidemiology, natural history, pathogenesis, and management of HIV/HBV co-infection from areas with high chronic hepatitis B prevalence.
References
More filters
Journal Article
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
N. E. Breslow,N. E. Day +1 more
TL;DR: What do you do to start reading statistical methods in cancer research vol ii the design and analysis of cohort studies?
Journal ArticleDOI
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Miriam J. Alter,Deanna Kruszon-Moran,Omana V. Nainan,Geraldine M. McQuillan,Fengxiang Gao,Linda A. Moyer,Richard A. Kaslow,Harold S. Margolis +7 more
TL;DR: The strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior, and poverty, having had 12 or fewer years of education, and having been divorced or separated were independently associated.
Journal ArticleDOI
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Yves Benhamou,Marie Bochet,V. Di Martino,Frédéric Charlotte,F. Azria,Anne Coutellier,Michel Vidaud,François Bricaire,Pierre Opolon,Christine Katlama,Thierry Poynard +10 more
TL;DR: In coinfected patients, a low CD4 count, alcohol consumption rate, and age at HCV infection are associated with a higher liver fibrosis progression rate, while HIV seropositivity accelerates HCV‐related liver Fibrosis progression.
Journal ArticleDOI
The multicenter aids cohort study: rationale, organization, and selected characteristics of the participants
TL;DR: The Multicenter AIDS Cohort Study was designed to elucidate the natural history of the infection causing acquired immunodeficiency syndrome (AIDS), identify risk factors for occurrence and clinical expression of the virus, and establish a repository of biologic specimens for future study.
Journal ArticleDOI
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
TL;DR: The data indicate that use of ritonavir may increase risk of severe hepatotoxicity, and does not support withholding protease inhibitor therapy from persons coinfected with hepatitis B or C virus.